Kerttu Orvokki Kalander

Kerttu Orvokki Kalander is a doctoral researcher affiliated with the Applied Tumor Genomics group at the University of Helsinki, participating in the Doctoral Programme in Biomedicine. Her work focuses on biomedical sciences, particularly tumor genomics and immunotherapy.

• Research activity spans two publications (2023 and 2025), targeting cancer immunotherapy advancements.
• Active participant in the iCAN retreat 2024 as a poster presenter.
• Email: kerttu.kalander@helsinki.fi

Research Trends: Recent publications emphasize CAR-T cell therapy and SH3-derived platforms for targeted immunotherapy, with applications in ovarian cancer models and protein engineering.

Network & Collaborations: Collaborates with researchers like S. Leppä, P.M. Ojala, and K. Saksela, focusing on translational cancer research.